Εξώφυλλο

NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS

Platelet P2Y12-receptor inhibitors are ranked 2nd in terms of administration frequency among antiplatelet agents (after acetylsalicylic acid). Administration of such drugs is mandatory in conditions characterized by increased activation of platelets, which, above all, include acute coronary syndrome...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	P. S. LAGUTA (Συγγραφέας), E. P. PANCHENKO (Συγγραφέας)
Μορφή:	Βιβλίο
Έκδοση:	«REMEDIUM GROUP» Ltd., 2017-12-01T00:00:00Z.
Θέματα:	article
Διαθέσιμο Online:	Connect to this object online.
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

P2Y<sub>12</sub> Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel
από: N. M. Vorobyeva
Έκδοση: (2019)

PRASUGREL: FREQUENTLY ASKED QUESTIONS FROM PRACTITIONERS
από: O. O. Shakhmatova, κ.ά.
Έκδοση: (2019)

EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?
από: Roman M. Shakhnovich
Έκδοση: (2018)

Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease
από: Martinelli Nicola, κ.ά.
Έκδοση: (2007)

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y Inhibitors
από: Patricia P. Wadowski MD, PhD, κ.ά.
Έκδοση: (2022)

WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME
από: M. Yu. Gilyarov, κ.ά.
Έκδοση: (2018)

ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors
από: Ronald Anderson, κ.ά.
Έκδοση: (2020)

P2Y12 Receptors in Tumorigenesis and Metastasis
από: Patrizia Ballerini, κ.ά.
Έκδοση: (2018)

<b>Development and validation of the discriminating method of prasugrel dissolution in tablets using ultraviolet detection
από: Camila Rigobello, κ.ά.
Έκδοση: (2014)

PRASUGREL FOR THE TREATMENT OF ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTION: STATUS UPDATE ON THE PROBLEM
από: O. O. Shakhmatova, κ.ά.
Έκδοση: (2018)

The Safeguarding Microglia: Central Role for P2Y12 Receptors
από: Si-Si Lin, κ.ά.
Έκδοση: (2021)

P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown
από: Susanna Amadio, κ.ά.
Έκδοση: (2014)

Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonists
από: Andrea Henrich, κ.ά.
Έκδοση: (2021)

In silico Investigation on Clopidogrel, Prasugrel and Ticagrelor as Potential Mono Antiplatelet Therapy for Acute Coronary Syndrome
από: Muhammad Naufal Hibatullah, κ.ά.
Έκδοση: (2024)

Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent Manner
από: Nina Wolska, κ.ά.
Έκδοση: (2020)

The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study
από: Yutaro Ide, κ.ά.
Έκδοση: (2024)

Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor
από: Fatemeh Haghighi, κ.ά.
Έκδοση: (2021)

MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
από: Rytkin E, κ.ά.
Έκδοση: (2021)

InterNICHE
από: COLAMA COLAMA 2012
Έκδοση: (2014)

InterNICHE
από: COLAMA COLAMA 2012
Έκδοση: (2014)

Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel
από: Uta Schilling, κ.ά.
Έκδοση: (2022)

Plugging the Gap and Niching the NICHE: Nursing Informatics Competencies for Higher Education
από: France Allan M. Cavite, κ.ά.
Έκδοση: (2022)

P2Y12 Receptor Antagonist Clopidogrel Attenuates Lung Inflammation Triggered by Silica Particles
από: Patricia Teixeira Santana, κ.ά.
Έκδοση: (2020)

Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013-2018
από: Arun Kumar, κ.ά.
Έκδοση: (2023)

Naturalist's Niche natuurhoekie
από: John Ledger
Έκδοση: (1988)

NEW PROSPECTS IN THE SECONDARY PREVENTION OF VENOUS THROMBOSIS
από: P. S. Laguta
Έκδοση: (2016)

CURRENT TREATMENT FOR VENOUS THROMBOSIS
από: P. S. Laguta
Έκδοση: (2015)

ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF STROKE
από: P. S. Laguta
Έκδοση: (2017)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
από: A. A. Lomonosova, κ.ά.
Έκδοση: (2015)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
από: A. A. Lomonosova, κ.ά.
Έκδοση: (2015)

Crosstalk between the osteogenic and neurogenic stem cell niches: how far are they from each other?
από: Maria Concetta Geloso
Έκδοση: (2016)

Microglia P2Y13 Receptors Prevent Astrocyte Proliferation Mediated by P2Y1 Receptors
από: Clara Quintas, κ.ά.
Έκδοση: (2018)

Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials
από: Pravesh Kumar Bundhun, κ.ά.
Έκδοση: (2017)

P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients
από: Niklas R. Jørgensen, κ.ά.
Έκδοση: (2017)

EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME
από: A. V. Rudakova, κ.ά.
Έκδοση: (2015)

EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME
από: A. V. Rudakova, κ.ά.
Έκδοση: (2015)

Niche Wars Australia in Afghanistan and Iraq, 2001-2014
Έκδοση: (2020)

Niche Wars Australia in Afghanistan and Iraq, 2001-2014
Έκδοση: (2020)

Adult Stem Cell Niches
Έκδοση: (2014)

The Hematopoietic Niche in Myeloproliferative Neoplasms
από: Annette H. Schmitt-Graeff, κ.ά.
Έκδοση: (2015)